Actively Recruiting
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
Led by Min-Seok Kim · Updated on 2024-01-05
160
Participants Needed
1
Research Sites
217 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to compare the impact of hemodynamic monitoring using pulmonary artery catheter (PAC) on survival and inotropic agent reduction in patients with cardiogenic shock caused by heart failure with reduced ejection fraction (HFrEF). The investigators also intend to compare the difference in long-term survival rates among patients who have recovered from cardiogenic shock due to HFrEF, based on the timing of initiation of beta-blocker treatment.
CONDITIONS
Official Title
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults age 19 and above (no age limit for elderly)
- Patients with cardiogenic shock requiring intensive care monitoring in ICU
- Patients eligible for oral medication administration
- Patients who have provided research participation consent through a written informed consent form
You will not qualify if you...
- Unwilling or unable to obtain informed consent by the participant or substitute decision maker
- Patients with mechanical circulatory support at the time of screening
- Patients with acute coronary syndrome
- Patients with severe valvular heart disease requiring emergent percutaneous procedures or surgery
- Known hypersensitivity to beta-blockers
- Patients with a history of bronchospasm or asthma
- Patients with bradycardia or second or third-degree atrioventricular block
- Patients with sick sinus syndrome, including sinoatrial block
- Patients with untreated pheochromocytoma
- Patients currently undergoing de-sensitization therapy
- Patients who are currently pregnant, postpartum period within 30 days or breast-feeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea, 05505
Actively Recruiting
Research Team
M
Min-Seok Kim, PhD
CONTACT
A
Ah-Ram Kim, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here